We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+40.03%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$649M
AUM Growth
+$219M
Cap. Flow
+$62.4M
Cap. Flow %
9.62%
Top 10 Hldgs %
92.83%
Holding
19
New
–
Increased
9
Reduced
–
Closed
2

Top Buys

Rank Stock Value
1
TSRO
TESARO, Inc.
TSRO
+$45.5M
2
PACB icon
Pacific Biosciences
PACB
+$15.2M
3
OPK icon
Opko Health
OPK
+$6.3M
4
PGEN icon
Precigen
PGEN
+$5.42M
5
BIOL
Biolase, Inc.
BIOL
+$5.27M

Top Sells

Rank Stock Value
1
HNSN
HANSEN MEDICAL, INC. COM NEW
HNSN
+$11.7M
2
TTHI
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
+$5.61M

Sector Composition

Rank Sector Weight
1 Healthcare 88.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXDX
1
DELISTED
Accelerate Diagnostics
AXDX
$139M 21.39%
509,273
+527
+0.1% +$117K
TSRO
2
DELISTED
TESARO, Inc.
TSRO
$116M 17.83%
1,154,322
+487,366
+73% +$45.5M
MZOR
3
DELISTED
Mazor Robotics Ltd.
MZOR
$71.6M 11.03%
2,766,517
– –
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
$66.8M 10.29%
2,671,936
+1,400
+0.1% +$32.6K
QDEL icon
5
QuidelOrtho
QDEL
$1.21B
$56M 8.62%
2,533,554
– –
OPK icon
6
Opko Health
OPK
$978M
$48.2M 7.42%
4,546,820
+632,820
+16% +$6.3M
PACB icon
7
Pacific Biosciences
PACB
$441M
$44.8M 6.9%
4,998,566
+1,816,297
+57% +$15.2M
BIOL
8
DELISTED
Biolase, Inc.
BIOL
$22.6M 3.48%
1,138
+296
+35% +$5.27M
AMRN
9
Amarin Corp
AMRN
$297M
$19.4M 3%
304,714
+20,135
+7% +$1.13M
PGEN icon
10
Precigen
PGEN
$2.36B
$18.6M 2.86%
668,606
+204,941
+44% +$5.42M
ARAY icon
11
Accuray
ARAY
$32.2M
$15.8M 2.44%
2,482,718
– –
AGEN
12
Agenus
AGEN
$326M
$14.3M 2.2%
101,127
+6,489
+7% +$744K
VRML
13
DELISTED
Vermillion, Inc.
VRML
$11.2M 1.73%
8,624,225
– –
CFRX
14
DELISTED
ContraFect Corporation
CFRX
$2.93M 0.45%
1,478
– –
BIIB icon
15
Biogen
BIIB
$29.8B
$2.1M 0.32%
6,723
– –
VANI icon
16
Vivani Medical
VANI
$115M
$179K 0.03%
2,117
– –
TCRT icon
17
Alaunos Therapeutics
TCRT
$4.66M
$38K 0.01%
44
– –
HNSN
18
DELISTED
HANSEN MEDICAL, INC. COM NEW
HNSN
– –
-4,491,820
Closed -$11.7M
TTHI
19
DELISTED
TRANSITION THERAPEUTICS INC (CANADA)
TTHI
– –
-3,817,972
Closed -$5.61M

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2016 Portfolio in Review

As of Q3 2016, Oracle Investment Management held 19 positions worth $649M, up 51% from $430M the previous quarter. Its ten largest holdings account for 93% of the portfolio.

Oracle Investment Management deployed $62.4M of net new capital in Q3 2016, adding to 9 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 89% of assets, up from 84% a quarter earlier.

On the sell side, the most notable exit was HANSEN MEDICAL, INC. COM NEW, an estimated $11.7M sold.

  • Oracle Investment Management added most to TESARO, Inc. in Q3 2016, an estimated $45.5M increase.
  • Oracle Investment Management fully exited HANSEN MEDICAL, INC. COM NEW in Q3 2016, selling an estimated $11.7M.
  • Oracle Investment Management's ten largest holdings make up 93% of its $649M portfolio in Q3 2016.
  • Oracle Investment Management opened 0 new positions and closed 2 in Q3 2016.
  • Oracle Investment Management's portfolio value rose 51% quarter-over-quarter to $649M.

Based on Oracle Investment Management's 13F filing for Q3 2016, filed 14 Nov 2016.